Karolin Bettge

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM GLP-1 receptor agonists (RAs) may cause nausea, vomiting or diarrhoea. The aim of this study was to assess the risk of adverse events (AEs) with GLP-1 RAs and their relation to dose, background medication and duration of action. RESEARCH DESIGN AND METHODS The PubMed database was searched and 32 clinical trials with GLP-1 RAs (phase 3) were selected.(More)
  • 1